Recent Finacing
Recent Raise
Carmenta Bioscience develops a diagnostic test for preeclampsia combining proprietary computational algorithms with novel serum protein biomarkers licensed from Stanford, and is advancing clinical validation toward a commercial launch.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor